Healthcare & Life Sciences
Neuron23
United Statesneuron23.com/
Neuron23 is a series c plus startup based in United States. 3 investors tracked.
series-c-plus
series-c-plus
Stage
2020
Founded
3
Investors
About Neuron23
Neuron23 is a company founded in 2020 headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
Neuron23 is a biotechnology company developing precision medicines and diagnostic approaches for Parkinson’s disease and other genetically defined neurological and immunological disorders by combining human genetics, data science, and patient-centered clinical strategies.
Explore Neuron23's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.